blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1106610

EP1106610 - Farnesyl transferase inhibiting 2-quinolone derivatives [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  22.04.2005
Database last updated on 02.11.2024
Most recent event   Tooltip08.05.2009Lapse of the patent in a contracting state
State(s) deleted from list of lapses: ES
published on 10.06.2009  [2009/24]
Applicant(s)For all designated states
Janssen Pharmaceutica NV
Turnhoutseweg 30
2340 Beerse / BE
[N/P]
Former [2004/25]For all designated states
Janssen Pharmaceutica N.V.
Turnhoutseweg 30
2340 Beerse / BE
Former [2001/24]For all designated states
Janssen Pharmaceutica N.V.
Patent Dept., Turnhoutseweg 30
2340 Beerse / BE
Inventor(s)01 / End, David William
1718 E. Butler Pike
Ambler, PA 19002 / US
02 / Venet, Marc Gaston, Janssen-Cilag S.A.
1, rue Camille Desmoulins, TSA 91003
92787 Cedex 9 Issy-les-Moulineaux / FR
03 / Angibaud, Patrick René, Janssen-Cilag S.A.
1, rue Camille Desmoulins, TSA 91003
92787 Cedex 9 Issy-les-Moulineaux / FR
04 / Sanz, Gérard Charles, Janssen-Cilag S.A.
1, rue Camille Desmoulins, TSA 91003
92787 Cedex 9 Issy-les-Moulineaux / FR
 [2001/24]
Application number, filing date01200450.325.10.1996
[2001/24]
Priority number, dateEP1995020294531.10.1995         Original published format: EP 95202945
[2001/24]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP1106610
Date:13.06.2001
Language:EN
[2001/24]
Type: B1 Patent specification 
No.:EP1106610
Date:16.06.2004
Language:EN
[2004/25]
Search report(s)(Supplementary) European search report - dispatched on:EP18.04.2001
ClassificationIPC:C07D401/06, C07D413/04, C07C225/22, A61K31/47
[2001/24]
CPC:
C07D231/12 (EP,US); C07D401/06 (EP,KR,US); A61K31/47 (KR);
A61P35/00 (EP); A61P43/00 (EP); C07D233/56 (EP,US);
C07D249/08 (EP,US) (-)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   NL,   PT,   SE [2001/24]
Extension statesLT13.12.2001
LV13.12.2001
RO13.12.2001
SI13.12.2001
TitleGerman:Farnesyltransferase hemmende 2-Chinolonderivate[2001/24]
English:Farnesyl transferase inhibiting 2-quinolone derivatives[2001/24]
French:Dérivés de 2-quinolone inhibant la farnesyle transferase[2001/24]
Examination procedure13.12.2001Examination requested  [2002/06]
01.12.2003Communication of intention to grant the patent
13.04.2004Fee for grant paid
13.04.2004Fee for publishing/printing paid
Parent application(s)   TooltipEP96937249.9  / EP1019395
Opposition(s)17.03.2005No opposition filed within time limit [2005/23]
Fees paidRenewal fee
08.06.2001Renewal fee patent year 03
08.06.2001Renewal fee patent year 04
08.06.2001Renewal fee patent year 05
31.10.2001Renewal fee patent year 06
31.10.2002Renewal fee patent year 07
31.10.2003Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCH16.06.2004
FI16.06.2004
LI16.06.2004
DK16.09.2004
GR16.09.2004
LU25.10.2004
SE26.10.2004
PT16.11.2004
[2009/24]
Former [2008/03]CH16.06.2004
FI16.06.2004
LI16.06.2004
DK16.09.2004
GR16.09.2004
ES27.09.2004
LU25.10.2004
SE26.10.2004
PT16.11.2004
Former [2007/09]CH16.06.2004
FI16.06.2004
LI16.06.2004
DK16.09.2004
GR16.09.2004
ES27.09.2004
LU25.10.2004
SE26.10.2004
Former [2005/48]CH16.06.2004
FI16.06.2004
LI16.06.2004
DK16.09.2004
GR16.09.2004
ES27.09.2004
SE26.10.2004
Former [2005/23]CH16.06.2004
FI16.06.2004
LI16.06.2004
DK16.09.2004
GR16.09.2004
ES27.09.2004
Former [2005/22]CH16.06.2004
FI16.06.2004
LI16.06.2004
DK16.09.2004
GR16.09.2004
Former [2005/06]CH16.06.2004
FI16.06.2004
LI16.06.2004
GR16.09.2004
Former [2005/02]CH16.06.2004
FI16.06.2004
LI16.06.2004
Former [2004/51]CH16.06.2004
LI16.06.2004
Documents cited:Search[A]JPS63275548  ;
 [A]US3900501  (NING ROBERT YE-FONG, et al) [A] 13 * column 4, formula V *;; example 2 *;
 [A]GB2103227  (CHEVRON RES [US]) [A] 13,14 * examples 1B,13A,13C *;
 [AD]EP0371564  (JANSSEN PHARMACEUTICA NV [BE]) [AD] 1,7 * see claims 1,8, tables 5-a, 6-a, 7-a, 8-a *;
 [A]EP0371559  (JANSSEN PHARMACEUTICA NV [BE]) [A] 1,7 * claims 1,7-10 *;
 [A]EP0574992  (GLAXO GROUP LTD [GB]) [A] 1,7 * claims 1,14 *;
 [A]EP0677513  (TAKEDA CHEMICAL INDUSTRIES LTD [JP]) [A] 1,7 * claims 1,2 *;
 [A]  - DATABASE WPI, 1, Derwent World Patents Index, vol. 1988, no. 51, Database accession no. 1988-365116, XP002164424 & JPS63275548 A 19881114 (SEISAN KAIHATSU KAGAKU KENKYUS) [A] 14 * abstract *
    [ ] - CHEMICAL ABSTRACTS, (19890717), vol. 111, no. 3, Database accession no. 23216z, page 586, XP002164423 [ ] * abstract *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.